Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cork

Showing results (121-130 of 224) with videos related to

Pageof 23
Sort By:
Journal of Food Science|December 17, 2013
Isolation and detection of extended spectrum β-lactamase (ESBL)-producing enterobacteriaceae from meat using chromogenic agars and isothermal loop-mediated amplification (LAMP) assaysM F Anjum, F Lemma, D J Cork, et al.
Human Genetics|August 15, 2000
Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome regionR Tazi-Ahnini, F S di Giovine, A J McDonagh, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 1, 2020
The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta-analysisZarif K Jabbar-Lopez, Chuin Ying Ung, Helen Alexander, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2006
New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactionsMichael J Cork, Darren A Robinson, Yiannis Vasilopoulos, et al.
The Journal of Dermatological Treatment|December 21, 2023
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trialDiala Alshiyab, Saleh A Ba-Shammakh, Abdulqudos Al-Fakih, et al.
American Journal of Clinical Dermatology|June 10, 2023
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6-11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III TrialElaine C Siegfried, Michael J Cork, Norito Katoh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2008
M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolateM L Sanderson-Smith, K Dinkla, J N Cole, et al.
The Journal of Dermatological Treatment|July 14, 2020
Vehicles for atopic dermatitis therapies: more than just a placeboSimon G Danby, Zoe D Draelos, Linda F Stein Gold, et al.
Human Genetics|February 18, 2003
Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areataR Tazi-Ahnini, M J Cork, D Wengraf, et al.
Dermatology and Therapy|April 25, 2026
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 TrialAmy S Paller, Michael J Cork, H Chih-Ho Hong, et al.
Pageof 23

Showing results (121-130 of 224) with videos related to

Sort By:
Pageof 23
Journal of Food Science|December 17, 2013
Isolation and detection of extended spectrum β-lactamase (ESBL)-producing enterobacteriaceae from meat using chromogenic agars and isothermal loop-mediated amplification (LAMP) assaysM F Anjum, F Lemma, D J Cork, et al.
Human Genetics|August 15, 2000
Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome regionR Tazi-Ahnini, F S di Giovine, A J McDonagh, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 1, 2020
The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta-analysisZarif K Jabbar-Lopez, Chuin Ying Ung, Helen Alexander, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2006
New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactionsMichael J Cork, Darren A Robinson, Yiannis Vasilopoulos, et al.
The Journal of Dermatological Treatment|December 21, 2023
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trialDiala Alshiyab, Saleh A Ba-Shammakh, Abdulqudos Al-Fakih, et al.
American Journal of Clinical Dermatology|June 10, 2023
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6-11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III TrialElaine C Siegfried, Michael J Cork, Norito Katoh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2008
M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolateM L Sanderson-Smith, K Dinkla, J N Cole, et al.
The Journal of Dermatological Treatment|July 14, 2020
Vehicles for atopic dermatitis therapies: more than just a placeboSimon G Danby, Zoe D Draelos, Linda F Stein Gold, et al.
Human Genetics|February 18, 2003
Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areataR Tazi-Ahnini, M J Cork, D Wengraf, et al.
Dermatology and Therapy|April 25, 2026
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 TrialAmy S Paller, Michael J Cork, H Chih-Ho Hong, et al.
Pageof 23